The Michigan Cannabis Manufacturers Association is encouraging its members to provide free or low-cost cannabis products to patients with severe or terminal illnesses.
MCMA’s Board of Directors unanimously passed a resolution last week that asks member companies to create a program to ensure seriously ill patients have access to low- or no-cost cannabis products that are tested, labeled, tracked, and licensed.
MCMA represents cannabis businesses across the state.
– Read the entire article at Metro Times.
Original Article
